Stroke Trial, Recruiting NCT07090057 Sponsor: University of Alberta Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07090057
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The patient (or their parent/guardian) must be able to give informed consent or assent in English
  • Patients must be children aged 4 to 17 years old who are already scheduled for surgery at Stollery Children's Hospital to treat a tightening of the ankle (called equinus contracture), either by lengthening the Achilles tendon or releasing a calf muscle
  • Patients must have one of the following known diagnoses: idiopathic toe walking, cerebral palsy, hereditary spastic paraparesis, traumatic brain injury, spinal cord or spinal tethering injury, hereditary sensory-motor neuropathy, or stroke
  • Patients must be able to hold their heel and mid-foot in a neutral (flat) position during assessment
  • The affected foot must be able to be bent downward (toward the floor) by more than 20 degrees, and by more than the degree of the ankle tightness (confirm with trial site)

Who may not be able to join:

  • People who are unable to provide informed consent or assent in English
  • People who have had previous surgery for ankle tightening (equinus)
  • People who have a limb difference or limb loss on the affected side
  • People who have a knee that cannot fully straighten, with a bend of more than 5 degrees
  • People who have had any surgery on the lower leg or foot of the affected side within the past 12 months
  • People who have received Botox (or a similar injection) below the affected knee within the past 6 months
  • People who have, or are suspected to have, a condition causing joint stiffness due to scar-like tissue in the joint (arthrofibrosis)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sukhdeep Dulai, MD, MHSc, FRCSC, University of Alberta

Phone: 780-492-2398

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
13 March 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Maximum passive ankle dorsiflexion; Maximum passive ankle dorsiflexion; Maximum passive ankle dorsiflexion; Maximum passive ankle dorsiflexion

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov